Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature;Neuropatía periférica durante un segundo ciclo de tratamiento con dosis altas de interferón alfa en un paciente con hepatitis C y revisión de la bibliografía

Revista de Neurologia

Volumn 35, Issue 7, 2002, Pages 644-646

  Téllez Zenteno, José Francisco ^a   Negrete Pulido, O ^a   Nunez M ^a   Estanol Vidal B ^a   Garcia Ramos G ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Alpha interferon; Hepatitis C virus; Peripheral neuropathy

Indexed keywords

ALPHA INTERFERON;

AGED; ARTICLE; CASE REPORT; DIAGNOSTIC ERROR; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ELECTROPHYSIOLOGY; HEPATITIS C; HUMAN; LONG TERM CARE; MALE; PARESTHESIA; PERIPHERAL NEUROPATHY;

EID: 0036826684     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3507.2001019     Document Type: Article

References (17)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, et al. The international Hepatitis Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized controlled trial. N Engl J Med 1989; 321: 1501-6.
2. Marcellin P, Boyer N, Giotra E, Degotte C, Couroce AM, Degos F, et al. Recombinant human α-interferon in patients with non-A, non-B hepatitis: a multicenter randomized controlled trial form France. Hepatology 1991; 13: 393-7.
3. Okanue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M. Side effects of high dose interferon therapy for chronic hepatitis C. J Hepatol 1996; 25: 283-91.
4. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, et al. Psychiatric complications of long term interferon alpha therapy. Arch Intern Med 1989; 147: 1577-80.
5. Manesis EK, Petrou C, Brouzas D, Hadziyannis S. Optic tract neuropathy complicating low-dose interferon treatment. J Hepatol 1994; 21: 474-7.
6. Purvin VA. Anterior ischemic neuropathy secondary to interferon alpha. Ach Ophthalmol 1995; 113: 1041-4.
7. Ogundipe O, Smith M. Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with hemorrhagic disorders. Haemophilia 2000; 6: 110-2.
8. Read SJ, Crawford DH, Pender MP. Trigeminal sensory neuropathy induced by interferon-alpha therapy (letter). Aust NZJ Med 1989; 89: 116.
9. Gastineuau DA, Habermann TM, Hermann RC. Severe neuropathy associated with low dose recombinant interferon-alpha. Am J Med 1989; 87: 116.
10. La Civita L, Zignego A, Lombardini F, Monti M, Longombardo G, Pasero G, et al. Exacerbation of peripheral neuropathy during alpha therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J Reumathol 1996; 23: 1641-3.
11. Zuber M, Gause A. Peripheral neuropathy during interferon-α therapy in patients with cryoglobulinemia and hepatitis virus infection. J Reumathol 1997; 24: 12.
12. Tambini R, Quatrini A, Fracssetti O, Nemmi R. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Reumathol 1997; 24: 8.
13. Emir S, Kutluk T, Chan KW, Yalcin B, Varli K, Buyukpamukcu M. Peripheral neuropathy during alpha-interferon therapy in a child with Hodgkin's disease. Pediatr Hematol Oncol 1999; 16: 557-60.
14. Negoro K, Fukusako T, Morimatsu M. Acute axonal polyneuropathy during interferon-α 2a therapy for chronic hepatitis C. Muscle Nerve 1994; 17: 1351-2.
15. Vesikari T, Nuutila A, Canteli K. Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma. Acta Paediatr Scand 1988; 77: 619-22.
16. Sakajiri K, Takamori M. Multiple mononeuropathy during recombinant interferon-alpha therapy for chronic hepatitis C. Rinsho Shinkeigaku 1992; 32: 1041-3.
17. Maeda M, Ohkoshi N, Hisihara S, Mizusawa H, Shoji S. Monoqneuropathy multiplex in a patient receiving interferon alpha therapy for chronic hepatitis C. Rinsho Shinkeigaku 1995; 35: 1048-50.